{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:27:33Z","timestamp":1773311253761,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejca.2017.11.027","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T09:40:50Z","timestamp":1513330850000},"page":"174-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["On\/off dropped head syndrome: A severe adverse event after prolonged treatment with MEK inhibitor"],"prefix":"10.1016","volume":"91","author":[{"given":"C.","family":"Longvert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Saiag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Aur\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.11.027_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00280-011-1620-1","article-title":"Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer","volume":"68","author":"Boasberg","year":"2011","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.ejca.2017.11.027_bib2","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1212\/WNL.0b013e318271f87e","article-title":"Dropped head syndrome: report of three cases during treatment with a MEK inhibitor","volume":"79","author":"Chen","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ejca.2017.11.027_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/CMR.0000000000000377","article-title":"Focal necrotizing myopathy with \u2019dropped-head syndrome\u201d induced by cobimetinib in metastatic melanoma","volume":"27","author":"Gauci","year":"2017","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2017.11.027_bib4","article-title":"Dropped-head syndrome in a patient under treatment with the MEK inhibitor trametinib for NRAS-mutated metastatic melanoma","author":"Kleemann","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejca.2017.11.027_bib5","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.bbamcr.2006.10.012","article-title":"RAF kinases and mitochondria","volume":"1773","author":"Galmiche","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejca.2017.11.027_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ejhg.2010.171","article-title":"Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway","volume":"19","author":"Kleefstra","year":"2011","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917314351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917314351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T03:08:26Z","timestamp":1535166506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917314351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":6,"alternative-id":["S0959804917314351"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.11.027","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On\/off dropped head syndrome: A severe adverse event after prolonged treatment with MEK inhibitor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}